| Mechanisms and therapeutic implications of hypermutation in gliomas M Touat, YY Li, AN Boynton, LF Spurr, JB Iorgulescu, CL Bohrson, ... Nature 580 (7804), 517-523, 2020 | 524 | 2020 |
| Helicobacter pylori: a poor man's gut pathogen? MM Khalifa, RR Sharaf, RK Aziz Gut pathogens 2, 1-12, 2010 | 327 | 2010 |
| Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy KB Einkauf, GQ Lee, C Gao, R Sharaf, X Sun, S Hua, SMY Chen, C Jiang, ... The Journal of clinical investigation 129 (3), 988-998, 2019 | 257 | 2019 |
| Contaminated water as a source of Helicobacter pylori infection: A review RK Aziz, MM Khalifa, RR Sharaf Journal of advanced research 6 (4), 539-547, 2015 | 193 | 2015 |
| The control of HIV after antiretroviral medication pause (CHAMP) study: posttreatment controllers identified from 14 clinical studies G Namazi, JM Fajnzylber, E Aga, RJ Bosch, EP Acosta, R Sharaf, ... The Journal of infectious diseases 218 (12), 1954-1963, 2018 | 181 | 2018 |
| Somatic HLA class I loss is a widespread mechanism of immune evasion which refines the use of tumor mutational burden as a biomarker of checkpoint inhibitor response M Montesion, K Murugesan, DX Jin, R Sharaf, N Sanchez, A Guria, ... Cancer Discovery 11 (2), 282-292, 2021 | 180 | 2021 |
| HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers R Sharaf, GQ Lee, X Sun, B Etemad, LM Aboukhater, Z Hu, ZL Brumme, ... The Journal of clinical investigation 128 (9), 4074-4085, 2018 | 87 | 2018 |
| Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic EA Williams, S Santagata, H Wakimoto, GM Shankar, FG Barker, R Sharaf, ... Acta neuropathologica communications 8, 1-10, 2020 | 80 | 2020 |
| Peripheral blood–derived virus-specific memory stem T cells mature to functional effector memory subsets with self-renewal potency M Schmueck-Henneresse, R Sharaf, K Vogt, BJD Weist, ... The Journal of Immunology 194 (11), 5559-5567, 2015 | 54 | 2015 |
| Integrative analysis of a large real-world cohort of small cell lung cancer identifies distinct genetic subtypes and insights into histologic transformation S Sivakumar, JA Moore, M Montesion, R Sharaf, DI Lin, CI Colón, ... Cancer discovery 13 (7), 1572-1591, 2023 | 53 | 2023 |
| Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV LB Giron, CS Palmer, Q Liu, X Yin, E Papasavvas, R Sharaf, B Etemad, ... Nature communications 12 (1), 3922, 2021 | 39 | 2021 |
| Effect of short-term antiretroviral therapy interruption on levels of integrated HIV DNA Z Strongin, R Sharaf, DJ VanBelzen, JM Jacobson, E Connick, ... Journal of virology 92 (12), 10.1128/jvi. 00285-18, 2018 | 37 | 2018 |
| Vulvar squamous cell carcinoma: comprehensive genomic profiling of HPV+ versus HPV–forms reveals distinct sets of potentially actionable molecular targets EA Williams, AJ Werth, R Sharaf, M Montesion, ES Sokol, DC Pavlick, ... JCO Precision Oncology 4, 647-661, 2020 | 36 | 2020 |
| The alphabet soup of HIV reservoir markers RR Sharaf, JZ Li Current HIV/AIDS Reports 14, 72-81, 2017 | 35 | 2017 |
| Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles EA Williams, N Shah, M Montesion, R Sharaf, DC Pavlick, ES Sokol, ... Modern Pathology 33 (8), 1466-1474, 2020 | 34 | 2020 |
| Melanoma with in-frame deletion of MAP2K1: A distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations EA Williams, M Montesion, N Shah, R Sharaf, DC Pavlick, ES Sokol, ... Modern pathology 33 (12), 2397-2406, 2020 | 29 | 2020 |
| HIV-1 balances the fitness costs and benefits of disrupting the host cell actin cytoskeleton early after mucosal transmission SM Usmani, TT Murooka, M Deruaz, WH Koh, RR Sharaf, M Di Pilato, ... Cell host & microbe 25 (1), 73-86. e5, 2019 | 25 | 2019 |
| Viral and host mediators of non-suppressible HIV-1 viremia A Mohammadi, B Etemad, X Zhang, Y Li, GJ Bedwell, R Sharaf, A Kittilson, ... Nature Medicine 29 (12), 3212-3223, 2023 | 22 | 2023 |
| Drug resistance mutations in HIV provirus are associated with defective proviral genomes with hypermutation Y Li, B Etemad, R Dele-Oni, R Sharaf, C Gao, M Lichterfeld, JZ Li Aids 35 (7), 1015-1020, 2021 | 21 | 2021 |
| Genomic profiling of combined hepatocellular cholangiocarcinoma reveals genomics similar to either hepatocellular carcinoma or cholangiocarcinoma K Murugesan, R Sharaf, M Montesion, JA Moore, J Pao, DC Pavlick, ... JCO precision oncology 5, 1285-1296, 2021 | 16 | 2021 |